Antibiotic stewardship in the ICU: time to shift into overdrive.
David MokraniJuliette ChommelouxMarc Pineton de ChambrunGuillaume HékimianCharles-Edouard LuytPublished in: Annals of intensive care (2023)
Antibiotic resistance is a major health problem and will be probably one of the leading causes of deaths in the coming years. One of the most effective ways to fight against resistance is to decrease antibiotic consumption. Intensive care units (ICUs) are places where antibiotics are widely prescribed, and where multidrug-resistant pathogens are frequently encountered. However, ICU physicians may have opportunities to decrease antibiotics consumption and to apply antimicrobial stewardship programs. The main measures that may be implemented include refraining from immediate prescription of antibiotics when infection is suspected (except in patients with shock, where immediate administration of antibiotics is essential); limiting empiric broad-spectrum antibiotics (including anti-MRSA antibiotics) in patients without risk factors for multidrug-resistant pathogens; switching to monotherapy instead of combination therapy and narrowing spectrum when culture and susceptibility tests results are available; limiting the use of carbapenems to extended-spectrum beta-lactamase-producing Enterobacteriaceae, and new beta-lactams to difficult-to-treat pathogen (when these news beta-lactams are the only available option); and shortening the duration of antimicrobial treatment, the use of procalcitonin being one tool to attain this goal. Antimicrobial stewardship programs should combine these measures rather than applying a single one. ICUs and ICU physicians should be at the frontline for developing antimicrobial stewardship programs.
Keyphrases
- multidrug resistant
- combination therapy
- intensive care unit
- gram negative
- public health
- mechanical ventilation
- primary care
- staphylococcus aureus
- end stage renal disease
- acinetobacter baumannii
- ejection fraction
- pseudomonas aeruginosa
- clinical trial
- chronic kidney disease
- mental health
- newly diagnosed
- antimicrobial resistance
- risk assessment
- prognostic factors
- patient reported outcomes
- study protocol
- candida albicans